Correlation Between Edgewise Therapeutics and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Cyclacel Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Cyclacel Pharmaceuticals
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Cyclacel is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Cyclacel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.45 times less risky than Cyclacel Pharmaceuticals. The stock trades about -0.27 of its potential returns per unit of risk. The Cyclacel Pharmaceuticals is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Cyclacel Pharmaceuticals on September 14, 2024 and sell it today you would lose (8.00) from holding Cyclacel Pharmaceuticals or give up 17.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Cyclacel Pharmaceuticals |
Edgewise Therapeutics and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Edgewise Therapeutics vs. Puma Biotechnology | Edgewise Therapeutics vs. Iovance Biotherapeutics | Edgewise Therapeutics vs. Day One Biopharmaceuticals | Edgewise Therapeutics vs. Inozyme Pharma |
| Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings | Cyclacel Pharmaceuticals vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |